Spark Neuro Inc.
EEG-based AI platform for rapid traumatic brain injury detection and monitoring
- Sector
- Medtech
- Headquarters
- New York, NY
- Founded
- 2018
- Latest Form D
- $13.3M, Jul 2018
- Total capital
- $22.3M
- Federal grants
- $9M
- 7 awards · 2020–2025
- Rank in peer group#51 of 538
- Private capital raised
- $13.3M
- 1 Form D · last Jul 2018
- 99 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 6 pending
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase II · Validation of a novel EEG-based neurodiagnostic platform for assessing cognitive impairment and Alzheimer's Disease$1.2M
- Federal grantHealth and Human S · Phase II · Validation of a novel EEG-based neurodiagnostic platform for assessing cognitive impairment and Alzheimer's Disease$1.3M
- Federal grantHealth and Human S · Phase II · Developing a novel EEG-based index for evaluating amyloid and tau burden in Alzheimer's Disease$1.2M
- Federal grantHealth and Human S · Phase II · Developing a novel EEG-based index for evaluating amyloid and tau burden in Alzheimer's Disease$1.3M
- Federal grantHealth and Human S · Phase I · Improving an EEG-based neurodiagnostic software platform to detect Alzheimer's Disease in MCI patients$300K
- Federal grantDefense · Phase II · EEG-Based Traumatic and Subconcussive Brain Injury Detector$2.7M
- Federal grantDefense · Phase II · SPARK Neuro Familiarity Detector$1.0M
- Private capital raisedForm D · SEC · 1st filing$13.3M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 538 peers
Line = medianMedtech · Device
- Federal grants#51 · top 9%
- Linked publications#75 · top 14%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- Jeremy SziklayExecutive Officer, DirectorNamed in SEC Form D filings
- Spencer GerrolExecutive Officer, DirectorNamed in SEC Form D filings
- William Ryan McGarryDirectorNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 6- PendingMethods And Systems For Detecting And Assessing Cognitive StatusUSPTOApplication 18758754
- PendingMethods And Systems For Detecting And Assessing Cognitive ImpairmentUSPTOApplication 18105384
- PendingMethods And Systems For Detecting And Assessing Cognitive StatusUSPTOApplication 63524073
Show all 6 patent records
- Methods And Systems For Detecting And Assessing Cognitive StatusJan 2, 2025 · Application 18758754Pending
- Methods And Systems For Detecting And Assessing Cognitive ImpairmentSep 7, 2023 · Application 18105384Pending
- Methods And Systems For Detecting And Assessing Cognitive StatusApplication 63524073Pending
- Methods And Systems For Detecting And Assessing Cognitive ImpairmentApplication PCTUS2023012274Pending
- Methods And Systems For Detecting And Assessing Cognitive ImpairmentApplication 63306915Pending
- Methods And Systems For Detecting The Presence Of Alzheimer's DiseaseApplication 63306914Pending
Recent research by its founders
- The long and small of it: language shapes duration estimation in speakers of English and Greek20260 cites
- Measuring electrophysiological changes induced by sub-concussive impacts due to soccer ball heading20254 cites
- Detecting undiagnosed dementia using medicare claims data20250 cites
Related companies, and why
- ASTRIN BIOSCIENCES, INC.Similar federal contract value in Medtech · null in contracts
- BiorasisSimilar federal contract value in Medtech · null in contracts
- PACE DIAGNOSTICSSimilar federal contract value in Medtech · null in contracts
- ELM TREE MEDICAL INC.Similar federal contract value in Medtech · null in contracts
- NeuroEM Therapeutics, Inc.Similar federal contract value in Medtech · null in contracts
- AMES TECHNOLOGY, INC.Similar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .